Familial polycystic ovarian disease.
Emphasis is placed on the heterogeneity of the phenotypic presentation of PCOD. It is the common expression of an unknown number of disorders and thus is a sign and not a specific diagnosis. Two essential features are arrested follicular maturation and atresia of follicles. Normal folliculogenesis is described, emphasizing that a large number of areas could be subject to derangement causing PCOD. Any interference of the finely balanced sequence of events can lead to PCOD. The genetic defect causing familial PCOD is unknown and the initiating event remains undefined. Three families are described that illustrate four features of familial PCOD. A number of associated disorders such as diabetes, hyperinsulinemia, obesity, and hypertension are described. The potential importance of agents that modulate the LH and FSH activity that may cause PCOD is emphasized. The theoretic means by which similar male and female gonadal abnormalities may be coupled in families through growth factors EGF and alpha TGF are presented.
Givens
J R
JR
Section of Reproductive Medicine, University of Tennessee, Memphis.
D000728:Androgens / Q000096:biosynthesis; D004967:Estrogens / Q000096:biosynthesis; D005260:Female; D006065:Gonadotropins, Pituitary / Q000378:metabolism; D006801:Humans; D008297:Male; D006080:Ovarian Follicle / Q000503:physiopathology; D010053:Ovary / Q000473:pathology / Q000503:physiopathology; D010375:Pedigree; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology
D000728:Androgens; D004967:Estrogens; D006065:Gonadotropins, Pituitary